- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 9.84M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 8.06M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 4.02M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 3.93M sh |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$9.02M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | $10.11M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$1.52M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | $18.39M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $1.01M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $1.1M |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $5.43M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $5.09M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $8.85M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $4.67M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$336K |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $342K |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | −$3.04M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $5.53M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $24.03M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $27.79M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $26.01M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $37.45M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $5.49M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $6.72M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $34.85M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $37.11M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.59 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$1.98 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$0.57 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$5.63 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.59 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$1.98 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$0.57 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$5.63 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $5.85M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $14.82M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $8.13M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $23.84M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $428K |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $870K |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $719K |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $1.33M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$5.85M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$15.98M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$10.13M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$2.29M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$22.13M |
| Net Income | Q2 2026 · Dec 31, 2024 | −$19.84M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$6.09M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$14.92M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$37.69M |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$7.83M |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$22.46M |
| Operating Income | Q2 2026 · Sep 30, 2024 | −$46.4M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $184K |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $765K |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $1.02M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $2.71M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $786K |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $2.08M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $1.49M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $2.97M |
| Revenue | Q2 2026 · Mar 31, 2026 | $970K |
| Revenue | Q2 2026 · Mar 31, 2026 | $2.85M |
| Revenue | Q2 2026 · Mar 31, 2025 | $2.51M |
| Revenue | Q2 2026 · Mar 31, 2025 | $5.68M |
| Capex | Q2 2026 · Mar 31, 2025 | $16K |